• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Incidence of Atrial Fibrillation following Alcohol Septal Ablation for Hypertrophic Cardiomyopathy.肥厚型心肌病酒精室间隔消融术后房颤的发生率
Ann Noninvasive Electrocardiol. 2016 Sep;21(5):443-9. doi: 10.1111/anec.12335. Epub 2016 Mar 11.
2
Incidence and predictors of late complete heart block after alcohol septal ablation treatment of hypertrophic obstructive cardiomyopathy.肥厚性梗阻性心肌病酒精室间隔消融治疗后晚期完全性心脏传导阻滞的发生率及预测因素
J Interv Cardiol. 2015 Feb;28(1):90-7. doi: 10.1111/joic.12178.
3
Surgical ablation of atrial fibrillation in hypertrophic obstructive cardiomyopathy: Outcomes of a tailored surgical approach.肥厚型梗阻性心肌病患者房颤的外科消融:一种定制化手术方法的结果
J Card Surg. 2020 Nov;35(11):2957-2964. doi: 10.1111/jocs.14946. Epub 2020 Aug 16.
4
Alcohol septal ablation in patients with concomitant hypertrophic cardiomyopathy and aortic valvular stenosis.酒精室间隔消融术治疗同时合并肥厚型心肌病和主动脉瓣狭窄的患者。
Catheter Cardiovasc Interv. 2020 Mar 1;95(4):830-837. doi: 10.1002/ccd.28442. Epub 2019 Aug 13.
5
Concomitant ablation for atrial fibrillation during septal myectomy in patients with hypertrophic obstructive cardiomyopathy.肥厚型梗阻性心肌病患者行心肌切除术同期行房颤消融术。
J Thorac Cardiovasc Surg. 2018 Apr;155(4):1536-1542.e2. doi: 10.1016/j.jtcvs.2017.08.063. Epub 2017 Sep 1.
6
Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.酒精间隔消融术治疗肥厚型梗阻性心肌病:已发表研究的系统评价
J Interv Cardiol. 2006 Aug;19(4):319-27. doi: 10.1111/j.1540-8183.2006.00153.x.
7
Predictors of Outcome After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: An Echocardiography and Cardiovascular Magnetic Resonance Imaging Study.酒精室间隔消融术治疗肥厚型梗阻性心肌病的预后预测因素:超声心动图和心血管磁共振成像研究。
Circ Cardiovasc Interv. 2016 Mar;9(3):e002675. doi: 10.1161/CIRCINTERVENTIONS.115.002675.
8
Relation of immediate decrease in ventricular septal strain after alcohol septal ablation for obstructive hypertrophic cardiomyopathy to long-term reduction in left ventricular outflow tract pressure gradient.酒精室间隔消融术治疗梗阻性肥厚型心肌病后室间隔应变立即下降与左心室流出道压力梯度长期降低的关系。
Am J Cardiol. 2009 Jun 1;103(11):1592-7. doi: 10.1016/j.amjcard.2009.01.373. Epub 2009 Apr 22.
9
Long-term outcomes of septal reduction for obstructive hypertrophic cardiomyopathy.梗阻性肥厚型心肌病间隔心肌切除术的长期疗效
J Cardiol. 2015 Jul;66(1):57-62. doi: 10.1016/j.jjcc.2014.08.010. Epub 2014 Sep 18.
10
Outcomes of Alcohol Septal Ablation in Younger Patients With Obstructive Hypertrophic Cardiomyopathy.酒精室间隔消融术治疗梗阻性肥厚型心肌病年轻患者的疗效。
JACC Cardiovasc Interv. 2017 Jun 12;10(11):1134-1143. doi: 10.1016/j.jcin.2017.03.030.

引用本文的文献

1
Advancements in the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Comprehensive Review.肥厚型心肌病的诊断与治疗进展:综述
J Cardiovasc Dev Dis. 2024 Sep 18;11(9):290. doi: 10.3390/jcdd11090290.
2
Atrioventricular nodal ablation and left bundle branch pacing for treatment of refractory atrial fibrillation post alcohol septal ablation for hypertrophic obstructive cardiomyopathy.房室结消融术和左束支起搏治疗肥厚性梗阻性心肌病酒精间隔消融术后难治性心房颤动
HeartRhythm Case Rep. 2021 Aug 21;7(11):754-757. doi: 10.1016/j.hrcr.2021.08.005. eCollection 2021 Nov.
3
The mechanisms, diagnosis and management of mitral regurgitation in mitral valve prolapse and hypertrophic cardiomyopathy.二尖瓣脱垂和肥厚型心肌病中二尖瓣反流的机制、诊断及处理
Discoveries (Craiova). 2016 Jun 30;4(2):e61. doi: 10.15190/d.2016.8.
4
Clinical and echocardiographic parameters as risk factors for atrial fibrillation in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者中作为心房颤动危险因素的临床和超声心动图参数
Clin Cardiol. 2018 Oct;41(10):1336-1340. doi: 10.1002/clc.23050. Epub 2018 Oct 16.

本文引用的文献

1
Incidence and predictors of late complete heart block after alcohol septal ablation treatment of hypertrophic obstructive cardiomyopathy.肥厚性梗阻性心肌病酒精室间隔消融治疗后晚期完全性心脏传导阻滞的发生率及预测因素
J Interv Cardiol. 2015 Feb;28(1):90-7. doi: 10.1111/joic.12178.
2
Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.超声心动图成人左心室容量和射血分数测量:美国超声心动图学会和欧洲心血管影像协会的更新建议。
J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14. doi: 10.1016/j.echo.2014.10.003.
3
Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical correlations, and mortality in a large high-risk population.肥厚型心肌病中的心房颤动:大型高危人群中的患病率、临床相关性及死亡率
J Am Heart Assoc. 2014 Jun 25;3(3):e001002. doi: 10.1161/JAHA.114.001002.
4
Left atrial wall thickness and outcomes of catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者左心房壁厚度与房颤导管消融的结局
J Interv Card Electrophysiol. 2014 Aug;40(2):153-60. doi: 10.1007/s10840-014-9894-y. Epub 2014 Apr 25.
5
Left atrial remodeling in hypertrophic cardiomyopathy and susceptibility markers for atrial fibrillation identified by cardiovascular magnetic resonance.肥厚型心肌病中心房重构和心血管磁共振识别的心房颤动易患标志物。
Am J Cardiol. 2014 Apr 15;113(8):1394-400. doi: 10.1016/j.amjcard.2013.12.045. Epub 2014 Jan 31.
6
Left ventricular systolic function following alcohol septal ablation for symptomatic hypertrophic cardiomyopathy.酒精室间隔消融术治疗肥厚型梗阻性心肌病的左心室收缩功能。
Am J Cardiol. 2014 Apr 15;113(8):1401-4. doi: 10.1016/j.amjcard.2014.01.417. Epub 2014 Jan 31.
7
Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review.肥厚型心肌病患者的心房颤动和血栓栓塞:系统评价。
Heart. 2014 Mar;100(6):465-72. doi: 10.1136/heartjnl-2013-304276. Epub 2013 Sep 7.
8
Long-term outcome of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: a Scandinavian multicenter study.经皮腔内室间隔心肌消融术治疗肥厚型梗阻性心肌病的长期疗效:一项斯堪的纳维亚多中心研究。
Circ Cardiovasc Interv. 2011 Jun;4(3):256-65. doi: 10.1161/CIRCINTERVENTIONS.110.959718. Epub 2011 May 3.
9
Meta-analyses of septal reduction therapies for obstructive hypertrophic cardiomyopathy: comparative rates of overall mortality and sudden cardiac death after treatment.梗阻性肥厚型心肌病间隔缩减治疗的荟萃分析:治疗后总死亡率和心源性猝死的比较发生率。
Circ Cardiovasc Interv. 2010 Apr;3(2):97-104. doi: 10.1161/CIRCINTERVENTIONS.109.916676. Epub 2010 Mar 2.
10
Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy.肥厚型心肌病间隔酒精消融与心肌切除术的更新荟萃分析。
J Am Coll Cardiol. 2010 Feb 23;55(8):823-34. doi: 10.1016/j.jacc.2009.09.047.

肥厚型心肌病酒精室间隔消融术后房颤的发生率

Incidence of Atrial Fibrillation following Alcohol Septal Ablation for Hypertrophic Cardiomyopathy.

作者信息

Moss Travis J, Zipse Matthew M, Krantz Mori J, Sauer William H, Salcedo Ernesto E, Schuller Joseph L

机构信息

Division of Cardiovascular Medicine, University of Virginia School of Medicine, Charlottesville, VA.

Division of Cardiology, University of Colorado Anschutz Medical Campus, Aurora, CO.

出版信息

Ann Noninvasive Electrocardiol. 2016 Sep;21(5):443-9. doi: 10.1111/anec.12335. Epub 2016 Mar 11.

DOI:10.1111/anec.12335
PMID:26970562
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6931872/
Abstract

BACKGROUND

Patients with hypertrophic cardiomyopathy (HCM) are at a fourfold to sixfold higher risk of developing atrial fibrillation (AF) compared to the general population, though incidence rates among patients undergoing alcohol septal ablation (ASA) are not well characterized. The purpose of this study was to evaluate atrial fibrillation incidence following ASA.

METHODS

We studied 132 consecutive HCM patients without comorbid AF that underwent 154 ASA procedures. The incidence of AF in follow-up was assessed through chart abstraction including electrocardiography. Survival free of AF was estimated using Kaplan-Meier methodology.

RESULTS

Over a mean follow-up of 3.6 ± 2.7 years (maximum 11.3 years), 10 (7.6%) patients developed new-onset AF. Of those who developed AF, both resting and provoked left ventricular outflow tract (LVOT) gradients had improved significantly (difference -79.78 mm Hg, P ≤ 0.005). Severity of mitral regurgitation improved in 7 (70%) patients. Survival free of AF was estimated to be 99.1%, 93.7%, and 91.7% at 1, 3, and 5 years.

CONCLUSIONS

Despite relieving LVOT obstruction and improving mitral regurgitation severity via ASA, new-onset AF remained a common complication of hypertrophic cardiomyopathy.

摘要

背景

肥厚型心肌病(HCM)患者发生心房颤动(AF)的风险比普通人群高4至6倍,不过酒精室间隔消融术(ASA)患者的发病率尚无明确特征。本研究旨在评估ASA术后心房颤动的发生率。

方法

我们研究了132例连续的无合并AF的HCM患者,他们接受了154次ASA手术。通过包括心电图在内的病历摘要评估随访期间AF的发生率。使用Kaplan-Meier方法估计无AF生存情况。

结果

平均随访3.6±2.7年(最长11.3年),10例(7.6%)患者出现新发AF。在发生AF的患者中,静息和激发状态下的左心室流出道(LVOT)梯度均有显著改善(差值-79.78 mmHg,P≤0.005)。7例(70%)患者的二尖瓣反流严重程度有所改善。估计1年、3年和5年无AF生存率分别为99.1%、93.7%和91.7%。

结论

尽管通过ASA缓解了LVOT梗阻并改善了二尖瓣反流严重程度,但新发AF仍是肥厚型心肌病的常见并发症。